Madeleine Armstrong

Madeleine has over 16 years’ experience writing about the biopharma and medtech industries. She joined ApexOnco in 2023, after eight years at Evaluate Vantage, most recently as News Editor. Before that, she was Deputy Editor of Clinica, a medical device publication, and has also worked for Scrip as a reporter. Madeleine also has experience moderating industry events and hosting webinars. She has a degree in Neuroscience, and has built a reputation as a leading voice in gene therapy.